ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01965106
Recruitment Status : Completed
First Posted : October 18, 2013
Last Update Posted : April 7, 2017
Sponsor:
Information provided by (Responsible Party):
Quark Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2015
  Actual Study Completion Date : July 2015
  Certification/Extension First Submitted : April 6, 2017